Original Articles
Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct
Authors:
M P B Goonetilleke ,
Paediatric Cardiology Unit, Teaching Hospital Karapitiya, LK
About M P B
Consultant Paediatric Cardiologist, Paediatric Cardiology Unit, Teaching Hospital Karapitiya
U A Jayarathna,
Paediatric Cardiology Unit, Teaching Hospital Karapitiya, LK
About U A
Medical Officer, Paediatric Cardiology Unit, Teaching Hospital Karapitiya
H A M Inthisar,
Paediatric Cardiology Unit, Teaching Hospital Karapitiya, LK
About H A M
Medical Officer, Paediatric Cardiology Unit, Teaching Hospital Karapitiya
N D Vithanage,
Paediatric Cardiology Unit, Teaching Hospital Karapitiya, LK
About N D
Medical Officer, Paediatric Cardiology Unit, Teaching Hospital Karapitiya
D R Palangasinghe,
Paediatric Cardiology Unit, Teaching Hospital Karapitiya, LK
About D R
Medical Officer, Paediatric Cardiology Unit, Teaching Hospital Karapitiya
P S Hettiarachchi,
Paediatric Cardiology Unit, Teaching Hospital Karapitiya, LK
About P S
Medical Officer, Paediatric Cardiology Unit, Teaching Hospital Karapitiya
P M W Madanayake
Paediatric Cardiology Unit, Teaching Hospital Karapitiya, LK
About P M W
Medical Officer, Paediatric Cardiology Unit, Teaching Hospital Karapitiya
Abstract
Objective: To describe early single-centre clinical experience with the Amplatzer Ductal Occluder II (ADO II).
Method: Children with a haemodynamically significant patent ductus arteriosus (PDA) who underwent percutaneous trans-pulmonary closure with Amplatzer Ductal Occluder II (ADO2) were included. Data was collected from computer based patient records.
Results: Trans-pulmonary PDA closures using ADO 2 were undertaken in 32 children (22 females) with a mean age of 1year 9 months (range 5 months to 10 years) and a mean weight of 8.2kg (range 4.2-25kg). Complete occlusion was noted pre-discharge in 31 (97%) patients. One (3%) had residual shunting after deployment followed by embolization to the left pulmonary artery on the third day of the procedure. One (3%) had mild flow acceleration in the left pulmonary artery and another (3%) had mild aortic flow obstruction following the procedure. At 7 and 30 days, echocardiography confirmed complete ductal occlusion without need for further intervention in all 31 (97%) successful cases.
Conclusion: ADO II is highly effective in rapid occlusion of morphologically varied small to moderate-sized PDAs.
(Key words: Ductal occluder; patent ductus arteriosus; trans-pulmonary; residual shunting)
Sri Lanka Journal of Child Health, 2014; 43(4): 201-204
DOI: http://dx.doi.org/10.4038/sljch.v43i4.7760
How to Cite:
Goonetilleke, M.P.B., Jayarathna, U.A., Inthisar, H.A.M., Vithanage, N.D., Palangasinghe, D.R., Hettiarachchi, P.S. and Madanayake, P.M.W., 2014. Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Sri Lanka Journal of Child Health, 43(4), pp.201–204. DOI: http://doi.org/10.4038/sljch.v43i4.7760
Published on
12 Dec 2014.
Peer Reviewed
Downloads
